Aarti Shah Biography and Net Worth

Aarti Shah is senior vice president and chief information and digital officer of Eli Lilly and Company. She has responsibilities for global information technology, information security, advanced analytics and data sciences, and digital health.

A Lilly veteran for over 25 years, Aarti has served in several functional and business leadership roles. She joined Lilly in 1994 as a senior statistician and was promoted to research scientist in 1999. She became vice president for biometrics in 2009 and led three global functions: global statistical sciences, data sciences and solutions, and global scientific communications. In 2013, she was named global brand development leader in Lilly’s Bio-Medicines business unit. She was promoted to senior vice president and became chief information officer in 2016.

Aarti received her bachelor’s and master’s degrees in statistics and mathematics in India before completing her Ph.D. in applied statistics from the University of California, Riverside.

Aarti serves on the board of Northwestern Mutual. She also serves on several nonprofit boards, including the Indiana India Business Council, the Center of Interfaith Cooperation, and Shrimad Rajchandra Love & Care USA. She served on the Indianapolis Public Library Foundation board for 9 years. In 2016, she was honored as a Woman of Influence by the Indianapolis Business Journal (IBJ) and was also named one of the Fierce Women in Biopharma by FiercePharma. In 2019, she was named one of the top four finalists for the 12th annual MIT Sloan CIO Leadership Award. She was named 2019 CTO of the Year (top honoree) by IBJ and TechPoint.

What is Aarti S. Shah's net worth?: The estimated net worth of Aarti S. Shah is at least $14.41 million as of April 14th, 2020. Dr. Shah owns 19,087 shares of Eli Lilly and Company stock worth more than $14,414,502 as of November 21st. This net worth approximation does not reflect any other assets that Dr. Shah may own. Learn More about Aarti S. Shah's net worth.
How do I contact Aarti S. Shah?: The corporate mailing address for Dr. Shah and other Eli Lilly and Company executives is LILLY CORPORATE CENTER, INDIANAPOLIS IN, 46285. Eli Lilly and Company can also be reached via phone at (317) 276-2000 and via email at [email protected]. Learn More on Aarti S. Shah's contact information.
Has Aarti S. Shah been buying or selling shares of Eli Lilly and Company?: Aarti S. Shah has not been actively trading shares of Eli Lilly and Company during the last ninety days. Most recently, Aarti S. Shah sold 2,000 shares of the business's stock in a transaction on Tuesday, April 14th. The shares were sold at an average price of $150.00, for a transaction totalling $300,000.00. Following the completion of the sale, the senior vice president now directly owns 19,087 shares of the company's stock, valued at $2,863,050. Learn More on Aarti S. Shah's trading history.
Who are Eli Lilly and Company's active insiders?: Eli Lilly and Company's insider roster includes Anat Ashkenazi (Sr. VP & CFO ), Melissa Barnes (SVP), Enrique Conterno (SVP), Stephen Fry (SVP), Michael Harrington (VP), Susan Mahony (SVP), Johna Norton (EVP), Myles O'Neill (SVP), Derica Rice (EVP), David Ricks (CEO), Marschall Runge (Director), Aarti Shah (SVP), Christi Shaw (SVP), Jeffrey Simmons (SVP), Daniel Skovronsky (SVP), Joshua Smiley (CFO), Jackson Tai (Director), Jacob Van Naarden (Sr. VP), Alonzo Weems (EVP), Anne White (SVP), Ilya Yuffa (SVP), Donald Zakrowski (CAO), and Alfonso Zulueta (SVP). Learn More on Eli Lilly and Company's active insiders.
Are insiders buying or selling shares of Eli Lilly and Company?: In the last year, insiders at the sold shares 26 times. They sold a total of 1,410,659 shares worth more than $1,192,819,015.29. The most recent insider tranaction occured on November, 8th when CAO Donald A Zakrowski sold 900 shares worth more than $723,042.00. Insiders at Eli Lilly and Company own 0.1% of the company. Learn More about insider trades at Eli Lilly and Company.
Information on this page was last updated on 11/8/2024.

Aarti S. Shah Insider Trading History at Eli Lilly and Company

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
4/14/2020	Sell	2,000	$150.00	$300,000.00	19,087
4/5/2019	Sell	1,800	$125.85	$226,530.00	18,425

Aarti S. Shah Buying and Selling Activity at Eli Lilly and Company

Eli Lilly and Company Company Overview

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Today's Range

Now: $755.20

$755.20

50 Day Range

MA: $872.25

$727.57

$935.09

2 Week Range

Now: $755.20

$561.65

$972.53

Volume

19,990 shs

Average Volume

3,171,825 shs

Market Capitalization

$716.93 billion

P/E Ratio

81.64

Dividend Yield

0.71%

Beta

0.43

Election warning coming true…

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - watch it before it's too late.

Click here to watch it now.